Pasithea Therapeutics Corp. (KTTAW) › RevenuePasithea Therapeutics Corp. (KTTAW) — RevenueAnnual figures by fiscal year, from SEC filings.2021: $15.1K2022: $486.6K$486.6K2021Revenue (USD)2022Fiscal YearRevenueChange YoY2022$486.6K+3130.4%2021$15.1K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share